Short-Chain Fatty Acids: The Complete Guide to Acetate, Propionate, and Butyrate (2026)
"Postbiotic" is having a moment. So is butyrate. Both of those words sit underneath a bigger, less marketed one: short-chain fatty acids.
Short-chain fatty acids (SCFAs) are organic compounds with fewer than six carbons, produced when gut bacteria ferment dietary fiber in the large intestine. The three main ones are acetate, propionate, and butyrate. They fuel colon cells, signal through receptors called FFAR2 and FFAR3, and influence immune and metabolic processes.
This is the parent page for everything we've written on butyrate, gut barrier, and fermentation. If you came here from one of those posts, start here and work back down.
Key takeaways
- Three SCFAs dominate: acetate, propionate, butyrate.
- Butyrate is the main fuel for colon lining cells.
- Only a small fraction of colonic butyrate reaches peripheral blood.
- Human appetite evidence is strongest for propionate, not butyrate.
- Fiber variety beats fiber quantity for SCFA production.
What are short-chain fatty acids?
You have roughly 100 trillion bacteria in your large intestine. They don't eat what you eat. They eat what you can't digest.
Fiber that survives your small intestine arrives in the colon intact. Bacteria ferment it, and short-chain fatty acids are the waste product. Waste for them, currency for you.
A 2025 review in Nature Reviews Microbiology describes SCFAs as compounds that "play diverse roles in different physiological processes of the host." That's careful phrasing, and it's careful for a reason. The chemistry is settled. What each one does in a living human is less settled than the supplement aisle suggests.
The three that matter by volume:
- Acetate (2 carbons), roughly 60% of the total
- Propionate (3 carbons), roughly 20%
- Butyrate (4 carbons), roughly 20%
Smaller amounts of valerate, caproate, and branched-chain SCFAs show up too. They're mostly a research curiosity so far.
Where do short-chain fatty acids come from?
Fiber, mostly. Some protein fermentation contributes, but that route also produces compounds you'd rather have less of.
Which fiber matters more than how much. Different bacterial species specialize, and the fermentation happens through cross-feeding chains. One species breaks a complex fiber into smaller pieces and releases acetate and lactate. A second species eats those and produces butyrate.
Which is why a person eating 40g of fiber a day from one source often produces less butyrate than someone eating 28g from eight sources. We went deeper on this in how to increase butyrate naturally.
Your gut bacteria don't run on fiber grams. They run on fiber variety.
Location matters too. Most fermentation happens in the right side of the colon, where fiber first arrives. By the time material reaches the left colon, the easily fermentable stuff is gone. That gradient is why slowly fermented fibers get research attention: they carry fermentation further along.
What does each short-chain fatty acid actually do?
They're not interchangeable. Each has a different fate once it's absorbed.
| SCFA | Share | Main fate | What it's studied for |
|---|---|---|---|
| Acetate | ~60% | Reaches peripheral tissues in the largest amounts | Lipid synthesis, cross-feeding substrate for butyrate producers |
| Propionate | ~20% | Largely taken up by the liver | Gluconeogenesis, appetite signaling (human RCT evidence) |
| Butyrate | ~20% | Consumed by colonocytes before it gets far | Gut barrier, HDAC inhibition, immune signaling |
Acetate is the one that actually circulates. It's also the raw material other bacteria use to build butyrate, so acetate production doubles as an input to the next step rather than a finished endpoint.
Propionate mostly gets pulled out by the liver on first pass. It feeds into gluconeogenesis there. It's also the SCFA with the cleanest human appetite data, which we'll get to.
Butyrate barely leaves the colon, because the cells lining your colon eat it. Butyrate is the primary energy source for colonocytes, which is unusual: most cells in your body prefer glucose. Colon cells prefer this.
Why is butyrate the one everyone talks about?
Two reasons, and only one of them is about butyrate being special.
The real one: butyrate does something the others don't. It inhibits histone deacetylases (HDACs), a class of enzymes that control which genes get read. That's a broad regulatory lever, and it's why butyrate turns up in research on inflammation, immunity, and barrier function. A 2018 review in Advances in Nutrition titled "Butyrate: A Double-Edged Sword for Health?" walks through both the HDAC pathway and the receptor pathway (FFAR2 and FFAR3), and is unusually honest that butyrate's role in obesity "remains controversial."
The marketing one: butyrate is the SCFA you can buy. Acetate is vinegar. Propionate is a bread preservative. Butyrate got a supplement category built around it, so it got the attention.
Worth separating those. If you want the form-by-form breakdown, we did that in sodium butyrate vs tributyrin and the butyrate supplement guide.
Do short-chain fatty acids affect appetite?
Here's where you have to be careful, because the honest answer splits by molecule.
Propionate: yes, with human trial evidence. In a randomized trial published in Gut, researchers built an inulin-propionate ester that carries propionate past the small intestine and releases it in the colon. In the acute arm, overweight adults given the ester ate significantly less at a test meal, with higher post-meal PYY and GLP-1 than the inulin-only control. In the 24-week arm, fewer participants in the propionate group gained 3% or more of body weight, and they gained less abdominal and liver fat.
A follow-up randomized study in Alimentary Pharmacology & Therapeutics confirmed that these inulin SCFA esters do what they claim mechanically: they deliver their payload to the colon rather than releasing it early.
Butyrate: the appetite work is preclinical. The mechanism people cite runs through L-cells, the intestinal cells that secrete GLP-1 and PYY. Butyrate stimulating those L-cells has been shown in mouse and cell studies. Human confirmation is still pending. We say "supports natural GLP-1 production" and stop there, on purpose, because a human trial that successfully raised circulating butyrate measured GLP-1 as a named secondary outcome and found no change.
The appetite data belongs to propionate. Butyrate has the mechanism and the mice.
That distinction gets flattened constantly in supplement copy, where "SCFAs reduce appetite" gets printed on a butyrate label. The category term is doing work the specific molecule hasn't earned yet.
Do short-chain fatty acids reach the brain?
This is the question underneath most of the gut-brain marketing, so it deserves a direct answer: partly, and less than the headlines imply.
There are three plausible routes. SCFAs can cross into circulation and reach the brain in small amounts. They can act on vagal afferents in the gut wall, sending a signal up the nerve without the molecule going anywhere. And they can trigger gut hormone release (GLP-1, PYY) that then acts centrally.
The second route is the one that probably does the most work, and it's the least glamorous, because nothing has to travel. A signal generated in your colon can change what your brain does without a single molecule of butyrate reaching your head.
Most of the direct brain evidence, though, is rodent work. Mouse studies show SCFAs affecting microglia, blood-brain barrier tightness, and feeding behavior. Human data on any of that is thin. When you see "gut-brain axis" on a label, that label is usually leaning on mice.
The one part with real human grounding is hormonal: the propionate trial above measured higher post-meal GLP-1 and PYY in people, and those hormones do act on appetite centers. That's a gut-to-brain effect with human evidence behind it, and it belongs to propionate specifically.
Can you measure your own SCFA levels?
Not usefully, and it's worth understanding why before you pay for a test.
Stool SCFA panels measure what's left over after your colon absorbed most of it. A low stool butyrate reading could mean you produced little, or it could mean you absorbed it efficiently. The test can't tell those apart.
Blood tests have a different problem. A 2015 randomized study in The Journal of Nutrition gave 12 patients a butyrate enema during abdominal surgery and sampled the portal vein, hepatic vein, and radial artery directly. Portal butyrate shot up (92.2 µmol/L versus 14.3 in placebo at 5 minutes). Then the liver took nearly all of it. Splanchnic release into systemic circulation didn't differ between groups at all.
So the liver is a gate. Butyrate made in your colon mostly gets used there or cleared on first pass, and only a small fraction reaches peripheral blood. That's a real constraint on the whole idea of "raising your butyrate" through fermentation, and it's the argument behind directly absorbed forms. We covered that trade-off in the lysine butyrate guide.
What has the research actually studied?
Sorted by strength, with populations labeled. Several of these enrolled people with a diagnosis, under medical supervision.
| Claim | Evidence | Species / population |
|---|---|---|
| Butyrate is the primary fuel for colonocytes | Established cell biology | Human tissue |
| Colonic propionate reduces acute energy intake | Randomized controlled trial | Human, overweight adults |
| Liver clears most butyrate before systemic circulation | Randomized, direct vessel sampling | Human, 12 surgical patients |
| SCFAs signal through FFAR2 / FFAR3 and inhibit HDACs | Mechanistic, review-level | Mixed, largely in vitro and rodent |
| Butyrate supports gut barrier function | Mechanistic + review | Cell and rodent models, some human |
| Butyrate stimulates GLP-1-secreting L-cells | Preclinical only | Mouse and cell studies |
| SCFAs modulate immune and inflammatory pathways | Large review literature | Heavily rodent; human work in disease populations |
Read that table as a map of where the science currently is. The rows with "human" attached are the ones you can lean on. The rest are directions, not conclusions.
Why do two people eating the same fiber get different results?
Because you're not really feeding yourself. You're feeding a specific population of organisms, and yours doesn't match your neighbor's.
Four things drive the difference:
- Which species you're carrying. Butyrate production is concentrated in a handful of groups, mainly Faecalibacterium prausnitzii, Roseburia, and Eubacterium rectale. If yours are low in abundance, the substrate arrives and nobody's home to use it.
- Transit time. Faster transit means less fermentation time and a different SCFA mix. This is one reason constipation and SCFA profiles are entangled in the literature.
- Colonic pH. SCFAs themselves lower gut pH, and lower pH favors butyrate producers over some competing species. Production is partly self-reinforcing.
- What else is in the diet. High protein intake shifts fermentation toward protein-derived metabolites. Alcohol and very low fiber intake both reduce the butyrate-producing population.
The 2022 Gut review on microbiome mechanisms makes the same point at a higher level: individual response to any dietary intervention varies substantially, and baseline microbiome composition is a big part of why. It's also why "eat more fiber" is decent advice that produces wildly different results across a room of people.
How do you increase short-chain fatty acid production?
Food first, because it's the only route that produces all three in the ratio your colon evolved with.
Widen the fiber sources, don't just raise the number. Aim for a mix across the week: oats and barley (beta-glucan), beans and lentils (resistant starch and galacto-oligosaccharides), onions, leeks, garlic and chicory root (inulin and fructans), green bananas and cooled cooked potatoes or rice (resistant starch), nuts and seeds.
Cook, cool, then eat. Cooling cooked starch converts some of it to resistant starch, which survives to the colon. Rice cooked and refrigerated overnight ferments differently from rice eaten hot. Reheating keeps most of the effect.
Go slow. A sudden jump from 15g to 40g of fiber produces gas, bloating, and a decision to quit. Add 5g a week.
Fermented foods are a different lever. Yogurt, kefir, kimchi, and sauerkraut add organisms rather than substrate. Useful alongside fiber, not instead of it.
Supplements are targeted, not comprehensive. A butyrate supplement delivers one SCFA and skips the fermentation entirely. A prebiotic fiber supplement does the opposite: it feeds the process and lets your bacteria decide the output. They do different jobs, and the honest position is that neither replaces a varied diet.
If your interest here is the gut-brain side of this (the part where fermentation ends up affecting cravings), that's covered in the gut-brain axis and gut health and GLP-1.
Where does Ozzi fit?
Ozzi is a drink stick you mix into 16oz of water. Two of its ingredients sit directly in this story, and I want to be exact about which does what.
500mg chicory root inulin. A prebiotic fiber that feeds butyrate-producing bacteria in your colon. This is the fermentation route: substrate in, SCFAs out, on your microbiome's terms.
500mg L-Lysine Butyrate (BIOMEnd). This is butyrate delivered directly rather than fermented. In a 2025 human crossover trial in 10 healthy men, lysine butyrate reached peak serum butyrate at 20 minutes, roughly 5 times tributyrin's peak. That's an absorption study, single dose, 10 people, no clinical outcomes. Call it a pilot and nothing more.
The rest of the stick works on cravings through other routes: 8g allulose for sweetness without the glucose spike, 500mg glucomannan for viscosity and stomach fullness, 150mg African mango, and 11mg chromium for insulin signaling support.
What Ozzi is not: it's not a treatment, and it's not going to fix a diet with no plants in it. It supports gut barrier function and natural GLP-1 production, and it gives the 9pm cravings somewhere to land.
Frequently asked questions
Are short-chain fatty acids the same as postbiotics?
SCFAs are the best-known example of a postbiotic, which is a broad term for beneficial compounds produced by microbes. All SCFAs are postbiotics. Not all postbiotics are SCFAs.
How many calories do SCFAs provide?
Estimates land around 5% to 10% of daily energy needs in people eating a typical fiber intake. That's a real contribution, and it's part of why fiber isn't truly zero-calorie.
Can you get SCFAs from food directly?
A little. Butter contains small amounts of butyrate, vinegar contains acetate, and some cheeses have propionate. The amounts are trivial compared with what your colon produces daily.
Do probiotics raise SCFA production?
Some strains do in some people, but the effect is inconsistent and strain-specific. Prebiotic fiber is the more reliable lever because it feeds whatever butyrate producers you already have.
Is more SCFA always better?
No. Very high systemic SCFA concentrations are potentially harmful, which is one reason researchers study liver clearance so closely. The Journal of Nutrition team explicitly framed their work as a safety question before therapeutic use.
Why does everyone say butyrate helps with leaky gut?
Because butyrate supports tight-junction integrity in cell and rodent models, and it fuels the cells that make up the barrier. That's mechanistically sound. It's also not the same as a human outcome trial. More on the terminology in leaky gut and inflammation.
Does antibiotic use lower SCFA production?
Typically yes, at least temporarily, because antibiotics reduce the bacterial populations doing the fermenting. Recovery timelines vary a lot between people.
Should I take a butyrate supplement or eat more fiber?
Fiber first. It produces all three SCFAs, feeds the ecosystem, and has the strongest evidence base of anything in this article. A butyrate supplement is a targeted add-on, not a substitute.
Does butyrate cause the smell people complain about?
Butyric acid is genuinely pungent. Different chemical forms handle it differently, and the lysine-bound form was rated most palatable in the 2025 crossover trial's taste testing. We wrote about it plainly in butyrate smell and taste, explained.
Butyrate and prebiotic fiber, in one stick
Crave Crusher mixes into 16oz of water. 500mg BIOMEnd L-Lysine Butyrate, 500mg chicory root inulin, 8g allulose, 500mg glucomannan, 11mg chromium.
Try it for 14 days straight. If it doesn't work, we'll refund your first bag.
References
- Mukhopadhya I, Louis P. Gut microbiota-derived short-chain fatty acids and their role in human health and disease. Nature Reviews Microbiology. 2025;23(10):635-651. https://doi.org/10.1038/s41579-025-01183-w
- Chambers ES, Viardot A, Psichas A, et al. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut. 2015;64(11):1744-1754. https://doi.org/10.1136/gutjnl-2014-307913
- van der Beek CM, Bloemen JG, van den Broek MA, et al. Hepatic uptake of rectally administered butyrate prevents an increase in systemic butyrate concentrations in humans. The Journal of Nutrition. 2015;145(9):2019-2024. https://doi.org/10.3945/jn.115.211193
- Liu H, Wang J, He T, et al. Butyrate: a double-edged sword for health? Advances in Nutrition. 2018;9(1):21-29. https://doi.org/10.1093/advances/nmx009
- Polyviou T, MacDougall K, Chambers ES, et al. Randomised clinical study: inulin short-chain fatty acid esters for targeted delivery of short-chain fatty acids to the human colon. Alimentary Pharmacology & Therapeutics. 2016;44(7):662-672. https://doi.org/10.1111/apt.13749
- Xiong RG, Zhou DD, Wu SX, et al. Short-chain fatty acids in diseases. Cell Communication and Signaling. 2023;21(1):212. https://doi.org/10.1186/s12964-023-01219-9
- de Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: mechanistic insights. Gut. 2022;71(5):1020-1032. https://doi.org/10.1136/gutjnl-2021-326789
- Zhang D, Jian YP, Zhang YN, et al. The interplay between gut microbiota, short-chain fatty acids, and implications for host health and disease. Gut Microbes. 2024;16(1):2393270. https://doi.org/10.1080/19490976.2024.2393270
Citations retrieved via PubMed. This article is for education only and isn't medical advice. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
